ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Premium IconPremium Help Menu
S&P 500
6,263.70
0.32%
Dow Jones
44,254.78
0.53%
US Dollar vs MXN
18.7193
-0.46%
Brent Oil
68.14
-0.29%
Bitcoin
118,788.12
0.84%
Pepperstone
AdvertisementAdvertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. TuHURA Biosciences Inc (HURA) Cotización

TuHURA Biosciences Inc

TuHURA Biosciences Inc (HURA)

Global X Uranium Index ETF
2.36
0.06
(2.61%)
Al cierre: 16 Julio 3:00PM
15 min retrasado - Mejora a Tiempo Real
2.35
-0.01
( -0.42% )
Fuera de horario: 5:00PM
15 min retrasado - Mejora a Tiempo Real

TuHURA Biosciences Inc (HURA) Cotización

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
2.35
( 2.17% )
Postura de Compra
2.30
Postura de Venta
2.35
Volume Operado de la Acción
229,286
2.23 Rango del Día 2.38
1.80 Rango de 52 semanas 7.93
Capitalización de Mercado [m]
102.649M
Precio Anterior
2.30
Precio de Apertura
2.29
Hora
20
@
2.3016
Última hora de negociación
18:02:05
Volumen financiero
US$ 524,718
Precio Promedio Ponderado
2.2885
Volumen promedio (3 m)
241,392
Acciones en circulación
43,680,396
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.55
Beneficio por acción (BPA)
-0.52
turnover
-
Beneficio neto
-22.65M

Acerca de TuHURA Biosciences Inc

TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It ... TuHURA Biosciences, Inc. is a Phase III registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first line treatment for advanced Merkel cell carcinoma. In addition, the Company is leveraging its Delta receptor technology to develop novel bi-functional antibody drug conjugates (ADCs), targeting myeloid derived suppressor cells to inhibit their immune suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. Its IFx platform technology utilizes a proprietary plasmid DNA (pDNA) or messenger RNA (mRNA). Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.kintara.com
Sede
Reno, Nevada, USA
Fundado
-
TuHURA Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HURA. The last closing price for TuHURA Biosciences was US$2.30. Over the last year, TuHURA Biosciences shares have traded in a share price range of US$ 1.80 to US$ 7.93.

TuHURA Biosciences currently has 43,680,396 shares in issue. The market capitalisation of TuHURA Biosciences is US$100.46 million. TuHURA Biosciences has a price to earnings ratio (PE ratio) of -4.55.

HURA Últimas noticias

Más noticias

Form 8-K - Current report
Edgar (US Regulatory)
30 Junio 2025
HURA (2.61%)

Form D - Notice of Exempt Offering of Securities
Edgar (US Regulatory)
13 Junio 2025
HURA (2.61%)

Form 8-K - Current report
Edgar (US Regulatory)
12 Junio 2025
HURA (2.61%)

Form 8-K - Current report
Edgar (US Regulatory)
06 Junio 2025
HURA (2.61%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.13-5.241935483872.482.552.261821072.38844685CS
4-0.05-2.083333333332.42.772.15207602.37773338CS
12-1.85-44.04761904764.24.32.12413922.72712103CS
26-2.34-49.89339019194.695.271.82312743.22082007CS
52-4.2-64.12213740466.557.931.82576904.00862653CS
156-4.2-64.12213740466.557.931.82576904.00862653CS
260-4.2-64.12213740466.557.931.82576904.00862653CS

HURA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de TuHURA Biosciences?
El precio actual de las acciones de TuHURA Biosciences es US$ 2.35
¿Cuántas acciones de TuHURA Biosciences están en circulación?
TuHURA Biosciences tiene 43,680,396 acciones en circulación
¿Cuál es la capitalización de mercado de TuHURA Biosciences?
La capitalización de mercado de TuHURA Biosciences es USD 100.46M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de TuHURA Biosciences?
TuHURA Biosciences ha negociado en un rango de US$ 1.80 a US$ 7.93 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de TuHURA Biosciences?
El ratio precio/beneficio de TuHURA Biosciences es -4.55
¿Cuál es la moneda de reporte de TuHURA Biosciences?
TuHURA Biosciences presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de TuHURA Biosciences?
El último beneficio anual de TuHURA Biosciences es USD -22.65M
¿Cuál es la dirección registrada de TuHURA Biosciences?
La dirección registrada de TuHURA Biosciences es 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
¿Cuál es la dirección del sitio web de TuHURA Biosciences?
La dirección del sitio web de TuHURA Biosciences es www.kintara.com
¿En qué sector industrial opera TuHURA Biosciences?
TuHURA Biosciences opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
XXII22nd Century Group Inc
US$ 7.24
(58.08%)
1.18M
SRPTSarepta Therapeutics Inc New
US$ 24.3488
(32.47%)
9.84M
ABVEAbove Food Ingredients Inc
US$ 2.16
(28.57%)
3.41M
DPRODraganfly Inc
US$ 6.50
(25.48%)
3.99M
OPENOpendoor Technologies Inc
US$ 1.75
(17.45%)
20.34M
CGBSCrown LNG Holdings Ltd
US$ 0.0162
(-56.33%)
116.29M
YHCLQR House Inc
US$ 8.791
(-18.07%)
4.08M
ZVSAZyVersa Therapeutics Inc
US$ 0.27
(-13.27%)
3.31M
SMXSMX Security Matters Public Company Ltd
US$ 1.61
(-11.05%)
3.17M
PTNMPitanium Ltd
US$ 12.05
(-10.14%)
16.12k
CGBSCrown LNG Holdings Ltd
US$ 0.0162
(-56.33%)
116.29M
OPENOpendoor Technologies Inc
US$ 1.75
(17.45%)
20.34M
BLMZBloomZ Inc
US$ 0.209
(5.82%)
9.95M
SRPTSarepta Therapeutics Inc New
US$ 24.3488
(32.47%)
9.84M
GTIGraphjet Technology
US$ 0.1058
(1.73%)
9.34M

Discusión

Ver feed completo
Skankhunt43 Skankhunt43 4 minutos hace
He posted two days ago. Did you want hourly updates?
DPLS
arachnodude arachnodude 4 minutos hace
I’m actually relieved I’m missing your point — because if that’s what passes for insight, I’ll stay off that bus, thanks.

You think selling silk “tomorrow” is the answer — as if dumping any material on the market before it meets elite spec will somehow prove something other than despe
KBLB
jesster64 jesster64 5 minutos hace
I appreciate the response but not fully getting it. NWBO applied using old manufacturing system dec 2023. If that manufacturing system was not good enough, application should have been rejected. Are you saying that now they are applying for major variation using flaskworks, since it is now in the ne
NWBO
Slojab Slojab 5 minutos hace
“Wow, amazing that Epstein ‘killed himself’ and Ghislaine is in federal prison for a hoax,” Musk wrote, blowing a hole in Trump’s claim.

https://www.msn.com/en-us/news/politics/elon-musk-blows-major-hole-in-trump-s-epstein-hoax-theory/ar-AA1IJTQK?ocid=hpmsn&cvid=c0499d9220f54fe7f1e52f
SamuraiAdventurer88 SamuraiAdventurer88 5 minutos hace
Bullish charts pump not their bs blogs. Fomo will be trapped.
HHSE
Bubae Bubae 6 minutos hace
No need for the reg A offering? 🙄 The business is net cash flow negative. The Q1 report shows the nearly $2 million net loss. This business of buying and reselling telcom connections is a low margin business. Revenue is deceptive here since the telcom connection they sell aren't free but wha
RDAR
sumbuysumsell sumbuysumsell 6 minutos hace
Good information. Thank you.
AVXL
delerious1 delerious1 6 minutos hace
House Fails to Advance CBDC Ban Amid Crypto Regulation Debate
Coin World
Wednesday, Jul 16, 2025 7:04 pm ET

2min read

The 5 Ws
Who: U.S. House of Representatives, Republicans, Democrats, Federal Reserve, crypto investors.
What: Failed to adva
XRPUSD
delerious1 delerious1 6 minutos hace
House Fails to Advance CBDC Ban Amid Crypto Regulation Debate
Coin World
Wednesday, Jul 16, 2025 7:04 pm ET

2min read

The 5 Ws
Who: U.S. House of Representatives, Republicans, Democrats, Federal Reserve, crypto investors.
What: Failed to adva
XLMUSD
BDEZ BDEZ 6 minutos hace
Almost babylon bee like stuff, Communists are delusional
MasterBlastr MasterBlastr 6 minutos hace
Nice - Delta Stag hopefully has a bright future for its customers and employees. Shareholders were toast long ago.
SVTE
IceCold8 IceCold8 6 minutos hace
We need that to happen to $CGAC @ARTDigital!!!
CGAC
Tomorrowneverknows Tomorrowneverknows 7 minutos hace
Ouch …$TWOH
TWOH
vlispxpert vlispxpert 7 minutos hace
LDI-if you thought OPEN was good, wait until LDI lights up ;)
glenn1919 glenn1919 7 minutos hace
DPRO......ZBAI.......FTRK.......................................a/h
DPRO FTRK ZBAI
BDEZ BDEZ 8 minutos hace
That's how they are in those crapholes...
arachnodude arachnodude 8 minutos hace
Oh stop with the theatrics! You’re not exposing failure — you’re exposing your own impatience. Because what you call “bullshit” is actually biotech discipline — and what you see as “brakes” is the controlled descent into commercial scale.

This isn’t about whether Kim understands.
KBLB
delerious1 delerious1 8 minutos hace
by Finance News Network Australia July 17, 2025 08:18 AM

US Crypto Bill Faces Republican Roadblock



Atrio of cryptocurrency regulation bills in the US Congress faces an uncertain future amid growing infighting among Republicans. Despite broad-based suppor
DOGEUSD
vlispxpert vlispxpert 8 minutos hace
GBIO we having fun yet?
GBIO
JMCK6193 JMCK6193 8 minutos hace
He can't,  he has a hard-on for DOGE.
DOGEUSD
Longstrongsilver Longstrongsilver 9 minutos hace
Yes I’ve run and still run successful businesses. I can understand there can be issues , but then maybe the answer is to stop saying stuff that doesn’t come to pass. He’s been a little better (except today too much of name calling again) but 100% he’s been too pumpy in the past. I’ve met several li
AZRH
rbtree rbtree 9 minutos hace
Spot on, Mister!!
KEGS

Su Consulta Reciente

NASDAQ
HURA
TuHURA Biosciences
Delayed Upgrade Clock
ADVFN
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN Ltd - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios